AddItIonal Keyphrases:expected range #{149}cutoff value forensic medicine #{149} abused drugs Cannabis (marijuana) is smoked or ingested for its psychoactive effects, delta-9-tetrahydrocannabinol (THC) being the major active constituent (1) . The concentration of THC in marijuana is believed to correlate with the magnitude of some psychological and physiological responses (2, 3) , and so analysis for THC in blood specimens is important for both pharmacological and forensic studies. Because THC is extensively associated with blood lipoproteins (4) , plasma or serum is the specimen of choice. THC concentrations in plasma can be determined by gas chromatography-mass spectrometry (5) , gas chromatography (6) , and radioimmunoassay (RIA) (7, 8) . For forensic studies, however, hemolyzed blood is often the only available sample. Gas chromatography-mass spectrometry (9) and RIA combined with "high-pressure" liquid chromatography Received Sept. 15, 1980; accepted Jan. 23, 1981. in that more samples can be analyzed rapidly at low concentrations, with small sample-volume requirements. In this report we describe the development of an RIA for THC that is useful in the analysis of either plasma or hemolyzed blood specimens. The use of an antibody of low cross reactivity, an '251-labeled delta-8-tetrahydrocannabinol of high specific activity as ligand (11, 12) , and a solid-phase double-antibody separation technique resulted in increased sensitivity and reproducibility.
Materials and Methods

Reagents and Standards
Preparation of radioligand. 5'-['251J1odo-delta-8-tetrahydrocannabinol was prepared by the method of Pitt et al. (12) except that a silica gel column was used for the final purification. The specific activity of the radioligand was about 250 kCi/mol (13). The stock solution was stored in benzene/ethanol (90/10 by vol) at 4#{176}C, protected from light. Chemical and radiochemical purity of the product was monitored by thinlayer radiochromatography.
A 
Controls.
Plasma and hemolyzed blood controls were prepared at 5 and 30 tg/L concentrations as described for plasma standards.
Plasma or hemolyzed blood specimens from subjects in a marijuana smoking study, described below, were also used as controls.
Plasma and hemolyzed blood unknowns. to check the anti-THC titer. The titer was defined as the dilution of serum that bound 50% of the radioligand (85 pg) in the absence of nonradioactive THC. The assay procedure was as described below, except that ammonium sulfate was used to separate bound from free radioactivity.
A marijuana
For cross-reactivity studies we used the serum with the highest titer.
RIA buffer. The pH 7.6 buffer consisted of, per liter, 50 mmol of tris(hydroxymethyl)aminomethane, 0.15 mol of NaCl, 1 g of bovine serum albumin, and 2 g of sodium aside.
Charcoal adsorbent. The fines were removed from charcoal (carbon decolorizing neutral Norit; Fisher Scientific Co., Fair
Lawn, NJ 07410) by repeated washings. The charcoal was activated by heating at 100#{176}C for 1 h. Working mixtures were prepared by adding 2 g of it to 100 mL of buffer, with stirring, in an ice bath. This concentration of charcoal gave optimum precipitation of bound radioactivity. A 0.5-mL aliquot was added to all tubes (except control tubes for total radioactivity) to remove free radioligand.
This (activity Inzero standard binding tube -nonspecific binding/total activity) X 100. After centrifugatlon to precipitate solid-phase second antibody, the sematant fluid was aspIrated and the radioactivity inthe pellet co,sited. d as C except that pellet was washed with buffer, centrifuged, and the supernatant fluid aspirated before counting.
nobeads';
Bio-Rad Laboratories, Richmond, CA 94804) were reconstituted with 50 mL of buffer. A 100-FL aliquot was used to precipitate antibody-bound radioactivity. This separation method was compared with the other separation methods.
Sample Preparation
Standards, controls, and unknowns (0.1 mL) were pipetted into silanized (Surfasil"; Pierce Chemical Co., Rockford, IL 61105) 10 X 75mm glass test tubes. The contents of each tube were vortex-mixed at low speed while 0.5 mL of methanol was added. After 15 mm (for plasma) or 30 mm (for hemolyzed blood) the tubes were centrifuged at 1000 X g for 15 mm. The methanolic supernatant fluid was used in the assay (10).
Assay Procedure
The radioligand in ethanol/water (1/1) was added to buffer to give a concentration of 80 pg/mL, and 0.5 mL was pipetted into 10 X 75 mm glass test tubes. Then 0.1 mL of the methanolic supernatant fluid from the sample preparation was added with a positive-displacement capillary pipet (micro! pettorTM; Scientific Manufacturing Industries, Inc., Berkeley, CA 94710) to appropriately labeled tubes, in duplicate. The anti-THC serum was diluted 25000-fold (20-35% antibody binding in the absence of analyte) with buffer, and 0.1 mL was added to all tubes except tubes for nonspecific binding and total radioactivity.
To those tubes 0.1 mL of buffer was added. The tubes were incubated at 4 #{176}C overnight, then 0.1 mL of the solid-phase second antibody was added to all tubes except the tubes used for determination of total counts. The tubes were incubated at 4 #{176}C for 2 h and then centrifuged at 1000 X g to precipitate antibody-bound radioactivity.
The supernatant fluid was aspirated and the pellet was washed with 1.0 mL of buffer. After centrifugation, the supernate was aspirated. The radioactivity was counted in a gamma counter with 72.6% efficiency as measured with 129! as a source. We calculated the concentrations of unknowns and controls from a standard curve, using the logit-log transformation of the average counts of duplicate tubes (14).
Comparison of AlA with Gas ChromatographyMass Spectroscopy
Twenty THC-positive and five THC-negative plasmas from the marijuana smoking study were analyzed by our RIA and by the gas chromatography-mass spectroscopy THC procedure of the Research Triangle Institute (5)4 The gas chromatography-mass spectroscopy procedure was sensitive to <2 g/L concentration, in a 1-mL sample. Reproducibility data were unavailable.
All samples were analyzed in a dou-
The GC-MS analysis was performed under National Institute on Drug Abuse contract No. 27-80-3721. 
Results
Comparison of Separation Methods
Assay Specificity
We compared the cross reactivities of each compound at the concentration needed (see above) to displace 50% of the radioligand from binding to the antibody. This concentration, divided by the 50% displaceipent concentration of THC (12 ig/L) and multiplied by 100, gave the relative percent cross reactivity. Table 2 shows the relative cross reactivities with the anti-delta-8-tetrahydrocannabinol rabbit serum of the three major cannabinoids in marijuana (THC, cannabinol, and cannabidiol), the two principal metabolites of THC (11- 
Reproducibility and Analyticai Recovery
Over a 10-week period, we assayed each of three plasma specimens from subjects in the marijuana smoking study 12 times. For hemolyzed blood, day-to-day reproducibility was determined for THC -supplemented samples 12 times during five months (Table 3) . We believe that this extended period of analysis provided a more realistic estimate of assay variability. Within-day reproducibility and analytical recovery were determined after adding a low and a high concentration of THC to plasma or hemolyzed blood ( Table 4) . The results for plasma specimens were better than those for hemolyzed blood specimens.
RIA Dose-Response Curves
We found antibody-specific binding of radioactivity to be consistently greater in the presence of methanolic extracts of plasma than in the presence of methanolic extracts of hemolyzed blood (see Table 1 ). Therefore, standard dose-responses were calculated separately for plasma and hemolyzed blood. Once the response for each type of standard was calculated, the logit-log plots were identical. Figure 1 illustrates the average dose-response curve for 10 consecutive assays (four plasma and six hemolyzed blood standard curves) during seven weeks.
Sensitivity of the Assay
The smallest measurable amount, determined at 2 SD below the mean of 10 determinations of binding in the absence of nonradioactive standard (data from Figure 1) chronic use or a lack of compliance with the request for four days of abstinence from smoking marijuana before the experiment.
We also analyzed 22 different presumed-negative forensic samples of hemolyzed blood, received through the North Carolina Medical Examiner's System. All had been stored at 4 #{176}C for longer than six months. We believed they Because false positives are totally undesirable, we arbitrarily set the cutoff for a positive sample at 3 SD above the mean concentration in our negative populations. Therefore, a specimen was considered positive if the apparent THC concentration was greater than or equal to 0.3 tg/L in plasma or 1.1 gfL in hemolyzed blood.
RIA Compared with Gas Chromatography-Mass Spectroscopy
Results 
Concentrations of THC in Human Plasma and Hemolyzed Blood
Further to validate the procedure, we analyzed in a double-blind fashion plasmas from five subjects, each of whom smoked a 1% THC marijuana cigarette. Our plot of the time after the start of smoking vs THC concentration in the plasma (Figure 3 ) resembles the data of Wall (16).
Whole blood was also collected from a man and a woman Comparison of results for THC In plasma samples from a marijuana smoking study as measured by the RIA and a gas chromatographic-mass spectrometric procedure during the smoking study. The plasma specimens were analyzed soon after the experiment by both gas chromatography-mass spectrometry and the RIA (Figure 2 ). The whole bloods were not analyzed by the RIA until eight months after the plasma specimens because the method had not then been developed.
The bloods were frozen and thawed to cause gross hemolysis.
The concentration in each hemolyzed blood specimen divided by the concentration in the corresponding plasma specimen and multiplied by 100 gave a mean value of 46% (CV, 30%) for the 18 positive samples. Unfortunately, the hematocrits were not determined on either subject, but this percentage would be consistent with a normal hematocnit.
Discussion
Analysis of hemolyzed blood specimens proved to be more difficult than analysis of plasma specimens, probably because of blood denaturation and high protein concentration. How- We considered it essential to have no false positives with the RIA because of the lack of convenient confirmatory methods, and so we arbitrarily set the cutoff for a positive sample at equal to or greater than 3 SD above the means for supposedly THC-negative samples. The smallest concentration detectable by this criterion was 0.3 tg/L in plasma and 1.1 ig/L in hemolyzed blood. We found no reports of pharmacological or forensic studies that require greater sensitivity.
In our comparison of our RIA with the Research Triangle Institute gas chromatography-mass spectrometry procedure for THC, the slope and y-intercept on linear-regression analysis of paired values suggests a systematic difference. We think this could in part be due to differences in THC bloodstandard preparation (e.g., different "negative" pools) and are currently testing this hypothesis. However, Wilcoxon's test, the sign test, and the coefficient of determination (r2) of the linear-regression model indicated excellent correlation between the two methods.
The RIA was over sixfold more sensitive than the gas chromatography-mass spectrometry procedure and required 0.1 as much sample. A gas chromatography-mass spectrometry method for THC in hemolyzed blood was unavailable; therefore, our RIA could not be directly compared for this type of specimen. However, whole-blood specimens were collected at the same time and from the same subjects as were 18 of the plasma specimens. The fact that the ratio of THC concentration in hemolyzed blood to that in plasma in these split specimens was consistent with a normal hematocrit increases our confidence in the accuracy of the RIA of hemolyzed blood. As a final validation of the RIA, we analyzed plasma samples from a marijuana smoking study in a double-blind fashion. The data for time after start of smoking vs concentration of THC in plasma were similar to those reported by others (Figure 3) . We found that the concentration of THC was highest during smoking. This was determined by comparing THC concentrations in the samples collected during and after completion of smoking. The ratio of the concentration found in hemolyzed blood to the concentration found in plasma specimens from split samples agreed well with the expected erythrocyte/whole blood volume ratio, i.e., the hematocrit.
This supports the findings of Rosenthal et al. (9), who compared the concentrations of THC found in four plasma and four hemolyzed blood specimens by gas chromatographymass spectrometry analysis, and of Klausner et al. (4), who predicted that THC would be found extensively in the plasma because of its high association with plasma proteins.
